One Year Sustainability of Risk Factor Change from a 9-Week Workplace Intervention
Table 2
Blood biochemistry for 50 subjects over 12 weeks.
Week 0
Week 3
Week 6
Week 9
Week 12
†P
Mean
±SD
Mean
±SD
Mean
±SD
Mean
±SD
Mean
±SD
Total cholesterol, mmol/L
5.7
±1.1
5.5
±1.0*
5.4
±1.0*
5.5
±1.0*
5.3
±1.0*
<.001
LDL cholesterol, mmol/L
3.6
±1.0
3.5
±0.9
3.4
±1.0*
3.4
±0.9*
3.3
±0.9*
<.001
HDL cholesterol, mmol/L
1.47
±0.31
1.40
±0.30
1.37
±0.30
1.46
±0.32
1.47
±0.31
‡.19
Total cholesterol /HDL
4.03
±1.11
4.08
±1.12
4.09
±1.11
4.00
±1.08
3.74
±0.95*
Triglyceride, mmol/L
1.3
±0.7
1.3
±0.7
1.3
±0.7
1.5
±0.9
1.2
±0.6
.59
Glucose, mmol/L
5.2
±0.5
5.1
±0.5
5.0
±0.5
5.0
±0.5
5.1
±0.5
.16
Insulin, pmol/L
56
±27
57
±29
53
±26
57
±28
54
±30
.49
HOMA B%
90
±28
93
±27
91
±27
97
±27
89
±27
.79
HOMA S%
121
±55
115
±66
122
±53
119
±54
120
±45
.12
AOA (μmol/L)
1221
±423
1260
±425
1293
±479
1338
±451*
1336
±514
.03
TBAR (mmol/L)
1.79
±0.25
1.77
±0.25
1.78
±0.23
1.79
±0.25
1.80
±0.25
.37
*Significantly different to week 0; †P value for changes over time by repeated measures ANOVA with sex as fixed effect (time sex effects were nonsignificant for all variables); ‡women significantly different to men, HOMA homeostatic model assessment, AOA antioxidant activity, TBAR thiobarbituric acid reactive substances.
